GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 23 filers reported holding GAIN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Citadel Advisors | 12,800 | $61,696 | 0.00% |
| Citadel Advisors | 100 | $482 | 0.00% |
| Citadel Advisors | 17,447 | $84,095 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 15,172 | $73,129 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 20,000 | $96,400 | 0.00% |
External links
This page lists GAIN THERAPEUTICS INC's shareholders in Q1 2023. To view GAIN THERAPEUTICS INC's shareholder history, click here.